BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6158640)

  • 1. Inhibition by purine compounds of cyclic GMP-stimulated cyclic AMP phosphodiesterase activity from a particulate fraction of rat striatum.
    Oleshansky MA
    Life Sci; 1980 Sep; 27(12):1089-95. PubMed ID: 6158640
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical stimulation by 1-methyl-3-isobutylxanthine of rat liver cyclic AMP phosphodiesterase activity.
    Erneux C; Miot F; Boeynaems JM; Dumont JE
    FEBS Lett; 1982 Jun; 142(2):251-4. PubMed ID: 6179796
    [No Abstract]   [Full Text] [Related]  

  • 3. Maintenance of meiotic arrest in mouse oocytes by purines: modulation of cAMP levels and cAMP phosphodiesterase activity.
    Downs SM; Daniel SA; Bornslaeger EA; Hoppe PC; Eppig JJ
    Gamete Res; 1989 Jul; 23(3):323-34. PubMed ID: 2476369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF; Shoji M; Brackett NL; Helfman DM
    J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
    Liang CM; Liu YP; Chabner BA
    Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of thyroid hormone on cyclic AMP phosphodiesterase in rat kidney.
    Hagino Y; Uematsu T; Tachibana M; Tsuru H
    Jpn J Pharmacol; 1980 Aug; 30(4):521-8. PubMed ID: 6162987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
    Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ
    J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C; Gauthier C; Le Bec A; Soustre H
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterase activity in bovine brain coated vesicles.
    Silva WI; Schook W; Mittag TW; Puszkin S
    J Neurochem; 1986 Apr; 46(4):1263-71. PubMed ID: 2869110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylxanthine effects on cyclic adenosine 3':5' monophosphate phosphodiesterase activity in preparations of neonatal rat cerebellum: modification by trifluoperazine.
    Dunlop M; Larkins RG; Court JM
    Biochem Biophys Res Commun; 1981 Feb; 98(3):850-7. PubMed ID: 6164367
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties and distribution of cyclic AMP phosphodiesterase from rat liver.
    Flawn P; Loten EG
    Int J Biochem; 1990; 22(9):983-8. PubMed ID: 1704319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
    Wells JN; Kramer GL
    Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS; Rhoads AR
    Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP analogs and selective inhibitors used to study low Km Mucor rouxii cAMP phosphodiesterase.
    Tomes C; Moreno S
    Int J Biochem; 1990; 22(9):1047-51. PubMed ID: 1704316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes.
    Weiss HR; Lazar MJ; Punjabi K; Tse J; Scholz PM
    Eur J Pharmacol; 2003 Nov; 481(1):25-31. PubMed ID: 14637171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal regulation of adipocyte particulate "low Km" cAMP phosphodiesterase.
    Manganiello VC; Smith CJ; Newman AH; Rice K; Degerman E; Belfrage P
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):497-511. PubMed ID: 2450112
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of phosphodiesterase isoenzymes in regulating intracellular cyclic AMP in adenosine-stimulated smooth muscle cells.
    Xiong Y; Westhead EW; Slakey LL
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):627-33. PubMed ID: 7832782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.